You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》啟明醫療(02500.HK)暗盤收39.4元 較上市價高19.4%
阿思達克 12-09 18:34

根據輝立交易平台顯示,明天掛牌的啟明醫療-B(02500.HK)暗盤高開12%報37元,最高見39.45元,收報39.4元,高上市價19.4%或6.4元。成交759萬股,涉資2.95億元。不計手續費,每手500股,賬面賺3,200元。

杭州啟明是內地領先的經導管心臟瓣膜醫療器械商。是次來港上市共發售7,853.75萬股H股,並已引入Hillhouse Capital、GIC、Aspex Master Fund、Cephei QFII China Total Return Fund及China Alpha Fund Management五名基石投資者,合共認購3,082.95萬股H股;其中10%公開發售獲逾311倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率僅30%;股份以招股範圍(29-33元)上限定價,料集資淨額24.11億元,主要用作分配至核心/其他產品/在研產品、透過內部研究或潛在收購持續擴充產品組合提供資金、以及支付有關收購Keystone代價等。上市聯席保薦人分別為高盛、中金、瑞信及招商證券。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account